Investigative analysis shows effective additive polymerization in norbornene using palladium catalysts, suggesting enhanced yield and activity.
A series of catalytic systems based on palladium complexes with phosphine-thioether ligands has been investigated in the additive polymerization of norbornene and its derivatives. The effects of the solvent nature and monomer concentration on the yield of the additive polynorbornenes synthesized in the presence of pre-catalysts of the (P,S)Pd(CH3)Cl structure, activated using AgSbF6, have been established. Cationic palladium complexes of the [(P,S)Pd(CH3)(L)]+(X)− composition (where L = CH3CN, DMSO, or 3,5-lutidine; X = BF4, SbF6) have been synthesized for the first time and characterized by means of 1H, 13C, and 31P NMR spectroscopy. Additive polymerization of norbornene in the presence of these cationic complexes has been investigated. The effect of the labile ligand and the counterion on the activity of the cationic palladium phosphine-thioether complexes in the additive polymerization of norbornene has been established. The activity of palladium cationic complexes in additive polymerization is significantly affected by the addition of B(C6F5)3, which binds the ligand L and promotes the dissociation of the complex into its active form.
No takes yet. Share an insight, caveat, or question.
Karpov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: